News Express
-
Crystal J. Yeo, MB BChir, PhD, Receives 2026 AANEM Scientific Impact AwardJuly 27, 2026
Crystal J. Yeo, MB BChir, PhD, is recognized with the AANEM 2026 Scientific Impact Award
-
James B. Meiling, DO, Receives 2026 AANEM Scientific Impact AwardJuly 27, 2026
James B. Meiling, DO, has been awarded the 2026 Scientific Impact Award.
-
Dale Colorado, DO, MPH, Receives 2026 AANEM Ernest Johnson Outstanding Educator AwardJuly 27, 2026
Dale Colorado, DO, MPH, has been named the 2026 Ernest Johnson Outstanding Educator Award recipient.
-
Kelly G. Gwathmey, MD, Receives 2026 AANEM Jun Kimura Outstanding Educator AwardJuly 27, 2026
Kelly G. Gwathmey, MD, has been named the 2026 AANEM Jun Kimura Outstanding Educator Award recipient.
-
William S. Pease, MD, Receives 2026 AANEM Advocacy AwardJuly 27, 2026
AANEM is proud to present the 2026 Advocacy Award to William S. Pease, MD, in recognition of his outstanding commitment to advancing patient care through leadership and advocacy.
-
Jeremy M. Shefner, MD, PhD, Receives 2026 AANEM Distinguished Researcher AwardJuly 27, 2026
Jeremy M. Shefner, MD, PhD, is recognized with the AANEM 2026 Distinguished Researcher Award.
-
Pushpa Narayanaswami, MD, Receives 2026 AANEM Distinguished Physician AwardJuly 27, 2026
Pushpa Narayanaswami, MD, has been awarded the 2026 Distinguished Physician Award.
-
Peter A. Grant, MD, Receives 2026 AANEM Lifetime Achievement AwardJuly 27, 2026
Peter A. Grant, MD, has been named the 2026 AANEM Lifetime Achievement Award recipient.
-
Aetna EDX Denials: Documentation and Appeal Guidance for PhysiciansJuly 08, 2026
AANEM has received reports of Aetna denying NCS and EMG claims when study counts exceed thresholds in its policy, even though the Maximum Numbers of Studies Table was intended as a general guideline, not a strict cap. Physicians should rely on Appendix J for accurate study counting and ensure documentation clearly explains the clinical rationale, especially in complex or atypical cases requiring additional testing. Thorough documentation and well-structured appeals are essential to demonstrate medical necessity and address inappropriate denials.
-
Science News: The Resisted Levator Scapulae Test: A Clinical Test for C4 RadiculopathyJune 15, 2026
The findings from this study highlight the clinical application of the RLS test as a new bedside diagnostic tool for patients with C4 radiculopathy.
-
AI-Generated Deepfakes and Physician Identity: What EDX and NM Clinicians Should Know
June 08, 2026
Advances in artificial intelligence are making it easier to create realistic, but fabricated, images, audio, and video. These “deepfakes” can replicate a physician’s voice, likeness, or clinical presence in ways that may be difficult for patients to distinguish from authentic content.
-
Patient Safety: Importance of Temperature in Nerve Conduction Studies
June 08, 2026
Ensuring appropriate limb temperature during electrodiagnostic testing is essential for accurate results. Lower temperatures can increase amplitudes, prolong latencies, and slow conduction velocities, potentially leading to misdiagnosis. Maintaining limb temperatures as appropriate (31° (lower) and 32° (upper) helps prevent technical artifacts and supports accurate clinical interpretation.
-
Science News: Muscle Involvement in Women Carrying Pathogenic DMD Gene Variants: A 6.5-Year Follow-up StudyMay 13, 2026
This study is valuable for neuromuscular clinicians because it provides rare, long‑term, quantitative data on how muscle involvement evolves in women carrying pathogenic DMD variants, a population that is frequently seen in clinic but historically understudied.
-
Science News: An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1April 28, 2026
While this is a small phase 1-2 clinical trial, this represents a novel disease modifying approach in a hereditary condition with only symptomatic treatment options currently.
-
Patient Safety: Electrodiagnostic Findings After Chemodenervation
April 10, 2026
Onabotulinum toxin inhibits acetylcholine release at the neuromuscular junction. Electrodiagnostic studies after therapeutic use may show abnormal spontaneous activity, motor unit morphology changes, and increased jitter at injection sites. EDX abnormalities have also been reported at distant sites. When EDX testing is performed for unrelated indications, results should be interpreted cautiously with these treatment effects in mind.
-
Science News: Fatigue: A Common but Poorly Understood Symptom in Neurological and Non-neurological DiseasesApril 08, 2026
Fatigue affects up to 60% of patients with NM disorders—so why do we still struggle to define and treat it?
-
AANEM Hill Day Advances Push for Quality, Safety, and Integrity in EDX MedicineMarch 19, 2026
AANEM members from across the country gathered in Washington, DC, on March 16 for Hill Day, turning a weather-disrupted event into a powerful show of advocacy for patients and the field of EDX medicine
-
Science News: Time to Recovery of Radial Nerve Palsy After Surgically Treated Humeral Shaft FracturesMarch 12, 2026
This retrospective study examined neurologic recovery in patients with complete radial nerve palsy associated with humeral shaft fractures treated with open reduction and internal fixation (ORIF). Among 471 patients with humeral fractures, 32 were identified with complete sensory and motor radial nerve palsy. Researchers assessed the time to first clinical signs of neurologic recovery and the time to full functional return.
-
Patient Safety: Complement inhibitors in treatment of myasthenia gravis
March 12, 2026
Complement inhibitors are used in treatment of anti-AChR-seropositive myasthenia gravis. Their use is associated with a greatly increased risk of potentially fatal meningococcal infections, and meningococcal vaccination is a mandatory step prior to starting treatment. Prescribing practitioners should enroll in REMS programs.
-
Remembering A. Robert Spitzer, MDMarch 04, 2026
The AANEM community remembers the life and legacy of Dr. A. Robert Spitzer, who passed away following a courageous battle with cancer.
